Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Female representation in dermatology is stable, but minority representation is low and needs improvement.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The research suggests that a specific skin gene can be controlled by signals within and between cells and is wrongly activated in certain skin diseases.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

The method can identify minerals in hair from water, and using coconut oil or conditioner can prevent mineral buildup.

Hair steroid measurement is an effective method to diagnose and monitor CAH in developing countries.

Alopecia affects self-confidence, body image, and social interactions, causing distress and requiring better support and awareness.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Older Black women in the UK feel more confident and engaged when their hair is visible and celebrated.

Boosting motivation can increase physical activity in women with PCOS.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.